P21 protein expression and ras-oncogene mutations in gastric carcinoma: Correlation with clinical data

International Journal of Oncology

Volumn 12, Issue 1, 1998, Pages 69-74

  Kasper, Hans Udo ^a,b   Schneider Stock, Regine ^a   Mellin, Walter ^a   Roessner, Albert ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Gastric cancer; P21 protein expression; Prognosis; Ras oncogene

Indexed keywords

PROTEIN P21; DNA; HRAS PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CODON; EXON; FEMALE; GENE EXPRESSION REGULATION; GENE LOCATION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; ONCOGENE RAS; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; ADENOCARCINOMA; ENZYME IMMUNOASSAY; GENETICS; INTESTINE TUMOR; METABOLISM; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATHOLOGY; STOMACH TUMOR;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; EXONS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, RAS; HUMANS; IMMUNOENZYME TECHNIQUES; INTESTINAL NEOPLASMS; MALE; MIDDLE AGED; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTO-ONCOGENE PROTEINS P21(RAS); STOMACH NEOPLASMS;

EID: 0031984432     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.12.1.69     Document Type: Article

References (38)

1. Bos JL: The ras gene family and human carcinogenesis. Mutat Res 195: 255-271, 1988.
2. Kiaris H and Spandidos DA: Mutations of ras genes in human tumours: a review. Int J Oncol 7: 413-421, 1995.
3. Barbacid M: ras genes. Ann Rev Biochem 56: 779-827, 1987.
4. Fuijta K, Ohuchi N, Yao T, Okumura M, et al: Frequent overexpression but not activation by point mutation of ras genes in primary human gastric cancer. Gastroenterology 93: 1339-1345, 1987.
5. Jiang W, Kahn SM, Guillem JG, et al: Rapid detection of ras oncogenes in human tumors: application to colon esophageal and gastric cancer. Oncogene 4: 923-928, 1989.
6. Craanen ME, Blok P, Top B, Boerrigter L, Dekker W, et al: Absence of ras gene mutations in early gastric cancer. Gut 37: 758-762, 1995.
7. Mitomi H, Uesugi H, Nishiyama Y, Ohida M, et al: Low epithelial cell proliferation and absence of oncoprotein expression in juvenile polyposis of the stomach, with or without tumors. Am J Gastroenterol 92: 1374-1377, 1997.
8. Kim TY, Bang Yj, Kim WS, Kang SH, et al: Mutation of ras oncogene in gastric adenocarcinoma: association with histological phenotype. Anticancer Res 17: 1335-1339, 1997.
9. Nanus DM, Kelsen DP, Mentle IR, Altorki N and Albino AP: Infrequent point mutation of ras oncogenes in gastric cancers. Gastroenterology 98: 955-960, 1990.
10. Carneiro F, David L, Sunkel C, et al: Immunohistochemical analysis of Ras oncogene p21 product in human gastric carcinomas and their adjacent mucosas. Pathol Res Pract 188: 263-272, 1992.
11. Weise B, Ghebremedhin E, Zschunke F and Radzun HJ: Optimization of restriction fragment length polymorphism and single strand conformation polymorphism analysis for the detection of point mutation of ras oncogenes in paraffin-embedded tissues. Gene Diagn Pathol 142: 45-52, 1996.
12. Lauren P: The two histological main types of gastric carcinoma: diffuse and so-called intestinal type carcinoma: an attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64: 31-94, 1965.
13. Orita M, Suzuki Y, Sekyia T and Hayashi K: Rapid and sensitive detection of point mutations and DNA polymorphism using the polymerase chain reaction. Genomics 5: 874-879, 1989.
14. Duffi MJ: Cellular oncogenes and supressor genes as prognostic markers in cancer. Clin Biochem 26: 439-447, 1993.
15. Bos JL, Verlaan-de Vries M, Marshall CJ, et al: A human gastric carcinoma contains a single mutated and an amplified normal allele of the Ki-ras oncogene. Nucleic Acids Res 14: 1209-1217, 1986.
16. Deng G, Liu X and Wang J: Correlation of mutation of oncogene c-Ha-ras at codon 12 with metastasis and survival of gastric cancer patients. Oncogene Res 6: 33-38, 1991.
17. Kihana T, Tsuda H, Hirota T, et al: Point mutation of c-Ki-ras oncogene in gastric adenoma and adenocarcinoma with tubular differentiation. Jpn J Cancer Res 82: 308-314, 1991.
18. Koshiba M, Ogawa O, Habuchi T, Hamazaki S, Shimada T, Takahashi R and Sugiyama T: Infrequent ras mutation in human stomach cancers. Jpn J Cancer Res 84: 163-167, 1993.
19. Lee KH, Lee JS, Suh C, Kim SW, Kim SB, Lee JH, Lee MS, Park MY, Sun HS and Kim SH: Clinicopathologic significance of the K-ras gene codon 12 point mutation in stomach cancer. Cancer 75: 2794-2801, 1995.
20. Miki H, Ohmori M, Perantoni AO and Enomoto T: K-ras activation in gastric epithelial tumors in Japan. Cancer Lett 58: 107-113, 1991.
21. Nagata Y, Abe M, Kobayashi K, et al: Glycine to aspartic acid mutations at codon 13 of the c-Ki-ras gene in human gastrointestinal cancers. Cancer Res 50: 480-482, 1990.
22. Nishida J, Kobayashi Y, Hirai H, et al: A point mutation at codon 13 of the N-ras oncogene in a human stomach cancer. Biochem Biophys Res Commun 164: 247-252, 1987.
23. O'Hara BM, Oskarsson M, Tainsky MA and Blair G: Mechanism of activation of human ras genes cloned from gastric adenocarcinoma and a pancreatic carcinoma cell line. Cancer Res 46: 4695-4700, 1986.
24. Shen C, Chang JG, Lee LS, et al: Analysis of ras gene mutation in gastrointestinal cancers. J Formosan Med Assoc 90: 1149-1154, 1991.
25. Kijima H, Abe Y, Yamazaki H, Ohnishi Y, Ueyama Y, Tamaoki N and Nakamura M: Stability of ras oncogene mutation in the human tumor xenografts through serial passages. Anticancer Res 14: 2583-2588, 1994.
26. Lin SY, Chen PH, Wang CK, Liu JD, et al: Mutation analysis of K-ras oncogenes in gastroenterologic cancers by the amplified created restriction sites method. Am J Clin Pathol 100: 686-689, 1993.
27. Victor T, Du Toit R, Jordaan AM, Bester AJ and van Helden PD: No evidence of point mutations in codons 12, 13, and 61 of the raj gene in a high-incidence area for esophageal and gastric cancer. Cancer Res 50: 4911-4914, 1990.
28. Deng G, Lu Y, Chen S, et al: Activated c-Ha-ras oncogene with a guanine to thymine transversion at the twelfth codon in a human stomach cancer cell line. Cancer Res 47: 3195-3198, 1987.
29. Koh EH, Chung HC, Lee KB, Han EK, Oh SH, Min JS, Choi EM, Youn JK and Kim BS: Point mutation at codon 12 of the c-Ha-ras gene in human gastric cancers. J Korean Med Science 7: 110-115, 1992.
30. Park JG, Yang HK, Kim WH, Chung JK, Kang MS, et al: Establishment and characterization of human gastric carcinoma cell lines. Int J Cancer 70: 443-449, 1997.
31. Czerniak B, Herz F, Gorczyca W and Koss LG: Expression of ras oncogene P21 protein in early gastric carcinoma and adjacent gastric epithelia. Cancer 64: 1467-1473, 1989.
32. Karayiannis M, Yiagnisis M, Padadimitriou K and Spandidos DA: Expression of the Ras oncoprotein in gastric carcinomas and adjacent mucosa. Anticancer Res 9: 1505-1510, 1989.
33. Ohuchi N, Horan HP, Merlo G, Fujita J, Mariani-Costantini R, Thor A, Nose M, Callahan R and Schlom J: Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridization. Cancer Res 47: 1413-1420, 1987.
34. Ranzani GN, Pellegata NS, Previdere C, Saragoni A, Vio A, Maltoni M and Amadori D: Heterogeneous protooncogene amplification correlates with tumor progression and presence of metastases in gastric cancer patients. Cancer Res 50: 7811-7814, 1990.
35. Spandidos DA and Wilkie NM: Malignant transformation of early passage rodent cells by a single mutated human oncogene. Nature 300: 143-149, 1982.
36. Motojiama K, Furui J, Kohara N, Izawa K, Kanematsu T and Shiku H: Expression of Kirsten ras P21 in gastric cancer correlates with tumor progression and is prognostic. Diagn Mol Pathol 3: 184-191, 1994.
37. Tahara E: Molecular biology of gastric cancer. World J Surg 19: 484-490, 1995.
38. Tahara E, Yasui W, Taniyama K, Ochial A, Yamamoto T, Nakajo S and Yamamoto M: Ha-ras oncogene product in human gastric carcinoma: correlation with invasiveness, metastasis or prognosis. Jpn J Cancer Res 77: 517-522, 1986.